We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rare Blood Types Due To Genetic Variation

By LabMedica International staff writers
Posted on 15 Mar 2012
Print article
Blood group typing is a routine procedure before blood transfusion, but some blood types, such as Langereis and Junior, are exceedingly rare worldwide.

While blood transfusion problems due to Langereis and Junior blood types are uncommon, several ethnic populations, such as certain Japanese populations and European Gypsies, are at risk.

An international team working with the University of Vermont (Burlington, VT, USA) used a multiplicity of analytical techniques including flow cytometry, immunofluorescence microscopy, mass spectrometry, and sequencing to identify the genetic basis of the Langereis blood group.

The scientists identified the human adenosine triphosphate (ATP)-binding cassette (ABC) transporter ABCB6 as the genetic basis of the Langereis blood group antigen expressed on red blood cells, but also at the plasma membrane of hepatocellular carcinoma (HCC) cells, and established that ABCB6 encodes a new blood group system (Langereis, Lan). Targeted sequencing of ABCB6 in 12 unrelated individuals of the Lan(−) blood type identified 10 different ABCB6 null mutations.

A Lan-specific monoclonal antibody has been developed and will greatly facilitate the identification of Lan(−) blood donors. In elucidating the genetic basis of the Lan(−) blood type, the scientists have uncovered ten null mutations of ABCB6. It will be necessary to closely monitor Lan(−) (ABCB6−/−) individuals, especially those treated with drugs potentially transported by ABCB6, because this deficiency may alter the pharmacokinetics of these drugs or result in adverse effects such as hepatotoxity. The authors concluded that transfusion support of individuals with an anti-Lan antibody is highly challenging partly because of the scarcity of compatible blood donors, but mainly because of the lack of reliable reagents for blood screening

Junior-negative blood donors are extremely rare too, but that may soon change. Bryan Ballif, PhD, an assistant professor at the University of Vermont and an author of the study said, "We're following up on more unknown blood types. There are probably on the order of 10 to 15 more of these unknown blood type systems, where we know there is a problem but we don't know what the protein is that is causing the problem. More than 50,000 Japanese are thought to be Junior negative and may encounter blood transfusion problems or mother-fetus incompatibility."

The study was published in the February 2012 issue of Nature Genetics.

Related Links:

University of Vermont


Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.